Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, visits or professional assistance with a real medical. We aren't doctors. Always consult your mD about Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy Clinical research trials and Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy health trials occur in a lot of of places throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to detect remedies for all varieties of circumstances, such as Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy. Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy Clinical Trials and other clinical trials allow volunteers to obtain health treatment choices before they are available to the general public. Most times the human subjects recieve professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy clinical trial. Human subjects frequently get the finest healthcare available for their Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy condition. Risks are a reality, however, and may include extra or frequent physician visits, medical dangers (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.

Home > "S" Clinical Trials Conditions > Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy

Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy



Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy

For Condition: Lipodystrophy
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) , University of Texas
Synopsis: OBJECTIVES: I. Determine the response in plasma norepinephrine concentration and plasma glycerol to the agonist (clonidine) and the antagonist (yohimbine) of the alpha-2 adrenergic receptor in 6 patients with regional lipoatrophy and in 6 controls. II. Determine the full sequence of the alpha-2 adrenergic receptor structural gene in genomic DNA from peripheral blood leukocytes.
Details: PROTOCOL OUTLINE: Antihypertensives are held, beginning 3 days before the first study day. An oral challenge is administered as follows: clonidine on day 1, yohimbine on day 2. The order of administration is reversed in alternate subjects. Timed measurements of norepinephrine, glycerol, and free fatty acids follow each challenge. Structural gene sequencing is evaluated for each participant.
Eligibility:
Study Type:  Observational, Screening
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Female
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Clinical diagnosis of regional lipoatrophy Control subjects: Women aged 18 to 65 Weight 90% to 150% of ideal No significant acute or chronic illness --Patient Characteristics-- Negative pregnancy test required of fertile women
Total Enrollment: 12

Location and Contact Information:

Overall Study Official:
FannieSmith,  Study Chair,  University of Texas

University of Texas Medical Branch
Galveston,  Texas,  77555-0209
United States
 


Additional Information:
Study ID Numbers:  199/11884;  UTMB-437
Study Start Date: November 1999
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004329

Other Lipodystrophy Studies:
1. Underlying abnormalities in fat and muscle leading to Lipodystrophy Syndrome

2. The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

3. Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy

4. A Study to determine how and why HIV-Infected subjects on anti-viral treatment develop Lipodystrophy

5. Changing to Nonprotease Inhibitor Treatment to Improve Side Effects

Related Studies:

Other Lipodystrophy Clinical Trials
Other Texas Clinical Trials
Other Galveston Clinical Trials

Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional Lipoatrophy
Modify your Search

  Other Lipodystrophy Clinical Trials
  Other Texas Clinical Trials
  Other Galveston Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103